Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, above historical average, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
34.50%
↑ 37% above average
Average (9y)
25.20%
Historical baseline
Range
High:120.32%
Low:-39.23%
CAGR
-3.3%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 34.50% |
| 2023 | 67.31% |
| 2022 | 120.32% |
| 2021 | -39.23% |
| 2020 | 39.71% |
| 2019 | 7.48% |
| 2018 | -8.78% |
| 2017 | -26.59% |
| 2016 | 10.51% |
| 2015 | 46.82% |